Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
editorial
. 2007 Feb 14;29(10):432–433. doi: 10.1002/clc.4960291003

An expanding role of biomarkers in acute aortic syndromes

Guglielmina Pepe 1, Betti Giusti 1, Magdi Yacoub 2,
PMCID: PMC6654030  PMID: 17063945

Full Text

The Full Text of this article is available as a PDF (41.9 KB).

References

  • 1. van der Loo B, Jenni R: Acute aortic syndrome: Proposal for a novel classification. Heart 2003; 89: 928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Fuster V: Novel cardiovascular biomarkers and implications for clinical trials. Nat Clin Prac Cardiovasc Med 2006; 3(2): 57 [DOI] [PubMed] [Google Scholar]
  • 3. Maisel AS, Bhalla V, Braunwald E: Cardiac biomarkers: A contemporary status report. Nat Clin Prac Cardiovasc Med 2006; 3(1): 24–34 [DOI] [PubMed] [Google Scholar]
  • 4. Robinson PN, Arteaga‐Solis E, Baldock C, Collod‐Beroud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, Kielty CM, Loeys B, Milewicz DM, Ney A, Ramirez F, Reinhardt DP, Tiedemann K, Whiteman P, Godfrey M: The molecular genetics of Marfan syndrome and related disorders. J Med Genet 2006. Mar 29; [Epub ahead of print] [DOI] [PMC free article] [PubMed]
  • 5. Gleason TG: Heritable disorders predisposing to aortic dissection. Semin Thorac Cardiovasc Surg 2005; 17(3): 274–281 [DOI] [PubMed] [Google Scholar]
  • 6. Uitto J: The Ehlers‐Danlos syndrome‐phenotypic spectrum and molecular genetics. Eur J Dermatol 2005; 15(5): 311–312 [PubMed] [Google Scholar]
  • 7. Plotkin H: Syndromes with congenital brittle bones. BMC Pediatr 2004; 4: 16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Giusti B, Porciani MC, Brunelli T, Evangelisti L, Fedi S, Gensini GF, Abbate R, Sani G, Yacoub M, Pepe G: Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. Eur Heart J 2003; 24: 2038–2045 [DOI] [PubMed] [Google Scholar]
  • 9. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G: High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000; 32: 531–536 [DOI] [PubMed] [Google Scholar]
  • 10. Fiotti N, Altamura N, Fisicaro M, Carraro N, Adovasio R, Sarra VM, Uxa L, Guarnieri G, Baxter BT, Giansante C: MMP‐9 microsatellite polymorphism: Association with the progression of intima‐media thickening and constrictive remodeling of carotid atherosclerotic plaques. Atherosclerosis 2005; 182(2): 287‐292 [Epub 2005 Feb 12] [DOI] [PubMed] [Google Scholar]
  • 11. Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R: Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vasc Surg 2004; 40(5): 995–1000 [DOI] [PubMed] [Google Scholar]
  • 12. Zhao L, Moos MP, Grabner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lotzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ, Funk CD: The 5‐lipoxygenase pathway promotes pathogenesis of hy‐perlipidemia‐dependent aortic aneurysm. Nat Med 2004; 10(9): 966–973 [DOI] [PubMed] [Google Scholar]
  • 13. Makita S, Ohira A, Tachieda R, Itoh S, Moriai Y, Yoshioka K, Niinuma H, Nakamura M, Hiramori K: Behavior of C‐reactive protein levels in medically treated aortic dissection and intramural hematoma. Am J Cardiol 2000; 86: 242–244 [DOI] [PubMed] [Google Scholar]
  • 14. Suzuki T, Katoh H, Tsuchio Y, Hasegawa A, Kurabayashi M, Ohira A, Hiramori K, Sakomura Y, Kasanuki H, Hori S, Aikawa N, Abe S, Tei C, Nakagawa Y, Nobuyoshi M, Misu K, Sumiyoshi T, Nagai R: Diagnostic implications of elevated levels of smooth‐muscle myosin heavy‐chain protein in acute aortic dissection. The smooth muscle myosin heavy chain study. Ann Intern Med 2000; 133(7): 537–541 [DOI] [PubMed] [Google Scholar]
  • 15. Suzuki T, Katoh H, Kurabayashi M, Yazaki Y, Nagai R: Biochemical diagnosis of aortic dissection by raised concentrations of creatine kinase BB‐isozyme. Lancet 1997; 350(9080): 784–785 [DOI] [PubMed] [Google Scholar]
  • 16. Shinohara T, Suzuki K, Okada M, Shiigai M, Shimizu M, Maehara T, Ohsuzu F: Soluble elastin fragments in serum are elevated in acute aortic dissection. Arterioscler Thromb Vasc Biol 2003; 23(10): 1839‐1844 [Epub 2003 Jul 3] [DOI] [PubMed] [Google Scholar]
  • 17. Suzuki T, Katoh H, Nagai R: Biochemical diagnosis of aortic dissection: From bench to bedside. Jpn Heart J 1999; 40: 527–534 [DOI] [PubMed] [Google Scholar]
  • 18. Eggebrecht H, Naber CK, Bruch C, Kroger K, von Birgelen C, Schmermund A, Wichert M, Bartel T, Mann K, Erbel R: Value of plasma fibrin D‐dimers for detection of acute aortic dissection. J Am Coll Cardiol 2004; 44: 804–809 [DOI] [PubMed] [Google Scholar]
  • 19. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA: Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004; 78: 2106–2111 [DOI] [PubMed] [Google Scholar]
  • 20. Takeuchi T, Adachi H, Ohuchida M, Nakamura T, Satoh A, Jacobs DR Jr, Imaizumi T: A case‐control study found that low albumin and smoking were associated with aortic dissection. J Clin Epidemiol 2004; 57: 386–391 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES